A computer software program developed at NJIT for early diagnosis of Alzheimers, Parkinsons and other diseases has won the most coveted title at a recent New Jersey Technology Council competition. Based at NJITs business incubator program, the Enterprise Development Center, NeuroTrax www.neurotrax.com, a start-up company, was named most likely to succeed. The event drew 60 young companies and 500 entrepreneurs and investors.
NeuroTrax develops and markets diagnostic products and devices for healthcare and life sciences. The debut product platform, Mindstreams, provides medical professionals and pharmaceutical companies with real-time objective measurement of cognitive function. This is critical for empowering early diagnosis and treatment for memory loss as well as outcome measurements for drug trials, said Ely Simon, MD.
NeuroTrax is the brainchild of founder and chief executive officer, Simon. Simon is a neurologist and adjunct instructor at Albert Einstein College of Medicine, Yeshiva University, NY. The company numbers among 83 similar technology enterprises based at NJITs Enterprise Development Center. The Center is New Jerseys pioneering business incubator program.
Patients with memory loss and other cognitive problems are now typically tested on paper by a neuropsychologist located outside the office who administers and scores the test. A full evaluation by a neuropsychologist is often impractical due to time and cost factors, Simon said. Mindstreams, however, is a step forward because it enables the physician to arrive at a faster diagnosis. The program also provides an easier and more reliable way for physicians to track the patients progress over time.
The interactive software program had initially focused on discovering mild cognitive impairment and the early detection of Alzheimers disease. The software program can also be used for early detection of Parkinso
|Contact: Sheryl Weinstein|
New Jersey Institute of Technology